Unfavourable outcomes for breast cancer have been linked to both low adiponectin levels and increased leptin levels [112, 113], and it is speculated that the adiponectin:leptin ratio may be more important for breast cancer growth than the absolute levels [114]. This evidence concerns the gene ADIPOQ and breast carcinoma.